Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 231

1.

A new cancer immunotherapy suffers a setback.

Garber K.

Science. 2018 May 11;360(6389):588. doi: 10.1126/science.360.6389.588. No abstract available.

PMID:
29748264
2.

Cytokine resurrection: engineered IL-2 ramps up immuno-oncology responses.

Garber K.

Nat Biotechnol. 2018 May 9;36(5):378-379. doi: 10.1038/nbt0518-378. No abstract available.

PMID:
29734296
3.

Nature Biotechnology's academic spinouts of 2017.

Branca MA, Garber K, DeFrancesco L.

Nat Biotechnol. 2018 Apr 5;36(4):297-306. doi: 10.1038/nbt.4121. No abstract available.

PMID:
29621217
4.

Tissue-agnostic cancer drug pipeline grows, despite doubts.

Garber K.

Nat Rev Drug Discov. 2018 Apr;17(4):227-229. doi: 10.1038/nrd.2018.6. Epub 2018 Mar 9. No abstract available.

PMID:
29520093
5.

Driving T-cell immunotherapy to solid tumors.

Garber K.

Nat Biotechnol. 2018 Mar 6;36(3):215-219. doi: 10.1038/nbt.4090. No abstract available.

PMID:
29509745
6.

A Framework for a Battlefield Trauma System for Civilians.

Garber K, Stewart BT, Burkle FM Jr, Kushner AL, Wren SM.

Ann Surg. 2018 Jul;268(1):30-31. doi: 10.1097/SLA.0000000000002691. No abstract available.

PMID:
29373367
7.

A framework for linking population model development with ecological risk assessment objectives.

Raimondo S, Etterson M, Pollesch N, Garber K, Kanarek A, Lehmann W, Awkerman J.

Integr Environ Assess Manag. 2018 May;14(3):369-380. doi: 10.1002/ieam.2024. Epub 2018 Feb 19.

PMID:
29271573
8.

First metabolic oncology inhibitor gets FDA green light, with record price tag.

Garber K.

Nat Biotechnol. 2017 Oct 11;35(10):895. doi: 10.1038/nbt1017-895. No abstract available.

PMID:
29020002
9.

Adenosine checkpoint agent blazes a trail, joins immunotherapy roster.

Garber K.

Nat Biotechnol. 2017 Sep 11;35(9):805-807. doi: 10.1038/nbt0917-805. No abstract available.

PMID:
28898225
10.

Attitudes Toward Morbidity and Mortality Conferences Among Medical and Surgical Pediatric Specialists in Armenia.

Rouch JD, Dawes AJ, Garber K, Sukhudyan B, Shekherdimian S.

JAMA Surg. 2017 Dec 1;152(12):1178-1180. doi: 10.1001/jamasurg.2017.2974. No abstract available.

PMID:
28854297
11.

In a major shift, cancer drugs go 'tissue-agnostic'.

Garber K.

Science. 2017 Jun 16;356(6343):1111-1112. doi: 10.1126/science.356.6343.1111. No abstract available.

PMID:
28619894
12.

Industry 'road tests' new wave of immune checkpoints.

Garber K.

Nat Biotechnol. 2017 Jun 7;35(6):487-488. doi: 10.1038/nbt0617-487. No abstract available.

PMID:
28591107
13.

Erratum: Drugging the gut microbiome.

Garber K.

Nat Biotechnol. 2017 May 9;35(5):481. doi: 10.1038/nbt0517-481b. No abstract available.

PMID:
28486466
14.

Mechanistic modeling of insecticide risks to breeding birds in North American agroecosystems.

Etterson M, Garber K, Odenkirchen E.

PLoS One. 2017 May 3;12(5):e0176998. doi: 10.1371/journal.pone.0176998. eCollection 2017.

15.

Oncologists await historic first: a pan-tumor predictive marker, for immunotherapy.

Garber K.

Nat Biotechnol. 2017 Apr 11;35(4):297-298. doi: 10.1038/nbt0417-297a. No abstract available.

PMID:
28398313
16.

A framework for predicting impacts on ecosystem services from (sub)organismal responses to chemicals.

Forbes VE, Salice CJ, Birnir B, Bruins RJ, Calow P, Ducrot V, Galic N, Garber K, Harvey BC, Jager H, Kanarek A, Pastorok R, Railsback SF, Rebarber R, Thorbek P.

Environ Toxicol Chem. 2017 Apr;36(4):845-859. doi: 10.1002/etc.3720. Review.

PMID:
28370293
17.

Worth the RISC?

Garber K.

Nat Biotechnol. 2017 Mar;35(3):198-202. doi: 10.1038/nbt.3810. Epub 2017 Feb 27. No abstract available.

PMID:
28244998
18.

Beyond a Moral Obligation: A Legal Framework for Emergency and Essential Surgical Care and Anesthesia.

Chawla KS, Rutkow L, Garber K, Kushner AL, Stewart BT.

World J Surg. 2017 May;41(5):1208-1217. doi: 10.1007/s00268-016-3866-6. Review.

PMID:
28180984
19.

Weight of evidence evaluation of a network of adverse outcome pathways linking activation of the nicotinic acetylcholine receptor in honey bees to colony death.

LaLone CA, Villeneuve DL, Wu-Smart J, Milsk RY, Sappington K, Garber KV, Housenger J, Ankley GT.

Sci Total Environ. 2017 Apr 15;584-585:751-775. doi: 10.1016/j.scitotenv.2017.01.113. Epub 2017 Jan 24. Review.

20.

Alnylam terminates revusiran program, stock plunges.

Garber K.

Nat Biotechnol. 2016 Dec 7;34(12):1213-1214. doi: 10.1038/nbt1216-1213. No abstract available.

PMID:
27926717
21.

Reassessment of Genomic Sequence Variation to Harmonize Interpretation for Personalized Medicine.

Garber KB, Vincent LM, Alexander JJ, Bean LJH, Bale S, Hegde M.

Am J Hum Genet. 2016 Nov 3;99(5):1140-1149. doi: 10.1016/j.ajhg.2016.09.015. Epub 2016 Oct 27.

22.

Big win possible for Ionis/Biogen antisense drug in muscular atrophy.

Garber K.

Nat Biotechnol. 2016 Oct 11;34(10):1002-1003. doi: 10.1038/nbt1016-1002. No abstract available.

PMID:
27727217
23.

Implementing school based telehealth for children with medical complexity.

Cormack CL, Garber K, Cristaldi K, Edlund B, Dodds C, McElligott L.

J Pediatr Rehabil Med. 2016 Sep 2;9(3):237-40. doi: 10.3233/PRM-160385.

PMID:
27612084
24.

Erratum: No longer going to waste.

Garber K.

Nat Biotechnol. 2016 Aug 9;34(8):888. doi: 10.1038/nbt0816-888b. No abstract available.

PMID:
27504779
25.

Cancer anabolic metabolism inhibitors move into clinic.

Garber K.

Nat Biotechnol. 2016 Aug 9;34(8):794-5. doi: 10.1038/nbt0816-794. No abstract available.

PMID:
27504761
26.

Two pioneering osteoporosis drugs finally approach approval.

Garber K.

Nat Rev Drug Discov. 2016 Jun 30;15(7):445-6. doi: 10.1038/nrd.2016.132. No abstract available.

PMID:
27357010
27.

Variants of uncertain significance in newborn screening disorders: implications for large-scale genomic sequencing.

Narravula A, Garber KB, Askree SH, Hegde M, Hall PL.

Genet Med. 2017 Jan;19(1):77-82. doi: 10.1038/gim.2016.67. Epub 2016 Jun 16.

PMID:
27308838
28.

Bristol-Myers Squibb locks into novel autoimmune strategy.

Garber K.

Nat Biotechnol. 2016 Jun 9;34(6):577-9. doi: 10.1038/nbt0616-577. No abstract available.

PMID:
27281396
29.

No longer going to waste.

Garber K.

Nat Biotechnol. 2016 May 6;34(5):458-61. doi: 10.1038/nbt.3557. No abstract available. Erratum in: Nat Biotechnol. 2016 Aug 9;34(8):888.

PMID:
27153267
30.

Participatory Genomic Testing as an Educational Experience.

Garber KB, Hyland KM, Dasgupta S.

Trends Genet. 2016 Jun;32(6):317-320. doi: 10.1016/j.tig.2016.03.008. Epub 2016 Apr 22. Review.

PMID:
27117243
31.

Natural killer cells blaze into immuno-oncology.

Garber K.

Nat Biotechnol. 2016 Mar;34(3):219-20. doi: 10.1038/nbt0316-219. No abstract available.

PMID:
26963532
32.

Alternative Therapeutic Approach in the Treatment of Oral Pyogenic Granuloma.

Bugshan A, Patel H, Garber K, Meiller TF.

Case Rep Oncol. 2015 Nov 14;8(3):493-7. doi: 10.1159/000441839. eCollection 2015 Sep-Dec.

33.

Participation in the Adoption Mentoring Partnership: Mentors' Experiences of Ethnic Identity.

Garber KJ, French QY, Grotevant HD.

New Dir Child Adolesc Dev. 2015 Dec;2015(150):77-89. doi: 10.1002/cad.20123.

PMID:
26650810
34.

Tumor macrophage target fuels $1.7-billion deal.

Garber K.

Nat Biotechnol. 2015 Dec 9;33(12):1222. doi: 10.1038/nbt1215-1222. No abstract available.

PMID:
26650003
35.

Predictive biomarkers for checkpoints, first tests approved.

Garber K.

Nat Biotechnol. 2015 Dec 9;33(12):1217-1218. doi: 10.1038/nbt1215-1217. No abstract available.

PMID:
26649999
36.

CELL BIOLOGY. Protein 'drops' may seed brain disease.

Garber K.

Science. 2015 Oct 23;350(6259):366-7. doi: 10.1126/science.350.6259.366. No abstract available.

PMID:
26494738
37.

Microaggressions, Feelings of Difference, and Resilience Among Adopted Children with Sexual Minority Parents.

Farr RH, Crain EE, Oakley MK, Cashen KK, Garber KJ.

J Youth Adolesc. 2016 Jan;45(1):85-104. doi: 10.1007/s10964-015-0353-6. Epub 2015 Sep 15.

PMID:
26374241
38.

RIKEN suspends first clinical trial involving induced pluripotent stem cells.

Garber K.

Nat Biotechnol. 2015 Sep;33(9):890-1. doi: 10.1038/nbt0915-890. No abstract available.

PMID:
26348942
39.

Community-Acquired Pyelonephritis in Pregnancy Caused by KPC-Producing Klebsiella pneumoniae.

Khatri A, Naeger Murphy N, Wiest P, Osborn M, Garber K, Hecker M, Hurless K, Rudin SD, Jacobs MR, Kalayjian RC, Salata RA, van Duin D, Perez F, Bonomo RA, Paterson DL, Harris PN.

Antimicrob Agents Chemother. 2015 Aug;59(8):4375-8. doi: 10.1128/AAC.00553-15.

40.

Cancer's copper connections.

Garber K.

Science. 2015 Jul 10;349(6244):129. doi: 10.1126/science.349.6244.129. No abstract available.

PMID:
26160924
41.

BIOMEDICINE. Targeting copper to treat breast cancer.

Garber K.

Science. 2015 Jul 10;349(6244):128-9. doi: 10.1126/science.349.6244.128. No abstract available.

PMID:
26160923
42.

A β-lactamase inhibitor revival provides new hope for old antibiotics.

Garber K.

Nat Rev Drug Discov. 2015 Jul;14(7):445-7. doi: 10.1038/nrd4666. No abstract available.

PMID:
26129790
43.

Alnylam's RNAi therapy targets amyloid disease.

Garber K.

Nat Biotechnol. 2015 Jun;33(6):577. doi: 10.1038/nbt0615-577a. No abstract available.

PMID:
26057960
44.

Drugging the gut microbiome.

Garber K.

Nat Biotechnol. 2015 Mar;33(3):228-31. doi: 10.1038/nbt.3161. Erratum in: Nat Biotechnol. 2017 May 9;35(5):481.

PMID:
25748907
45.

Oncologists push beyond new lung cancer genomic testing guidelines.

Garber K.

J Natl Cancer Inst. 2015 Feb 12;107(2). pii: djv023. doi: 10.1093/jnci/djv023. Print 2015 Feb. No abstract available.

PMID:
25677038
46.

Promising early results for immunotherapy-antiangiogenesis combination.

Garber K.

J Natl Cancer Inst. 2014 Nov 23;106(11). pii: dju392. doi: 10.1093/jnci/dju392. Print 2014 Nov. No abstract available.

PMID:
25421345
47.

Bispecific antibodies rise again.

Garber K.

Nat Rev Drug Discov. 2014 Nov;13(11):799-801. doi: 10.1038/nrd4478. No abstract available.

PMID:
25359367
48.

Translational analysis of effects of prenatal cocaine exposure on human infant cries and rat pup ultrasonic vocalizations.

Zeskind PS, McMurray MS, Cox Lippard ET, Grewen KM, Garber KA, Johns JM.

PLoS One. 2014 Oct 22;9(10):e110349. doi: 10.1371/journal.pone.0110349. eCollection 2014.

49.

Early postpartum pup preference is altered by gestational cocaine treatment: associations with infant cues and oxytocin expression in the MPOA.

Lippard ET, Jarrett TM, McMurray MS, Zeskind PS, Garber KA, Zoghby CR, Glaze K, Tate W, Johns JM.

Behav Brain Res. 2015 Feb 1;278:176-85. doi: 10.1016/j.bbr.2014.09.045. Epub 2014 Oct 6.

50.

Towards understanding RNA-mediated neurological disorders.

Duan R, Sharma S, Xia Q, Garber K, Jin P.

J Genet Genomics. 2014 Sep 20;41(9):473-84. doi: 10.1016/j.jgg.2014.08.003. Epub 2014 Aug 23. Review.

Supplemental Content

Loading ...
Support Center